Updated Safety Data Of The Dante Trial: Perioperative Atezolizumab In Combination With Flot Versus Flot Alone In Patients With Resectable Esophagogastric Adenocarcinoma - A Randomized, Open-Label Phase Ii Trial Of The German Gastric Group At The Aio And Sakk

Annals of Oncology(2020)

引用 5|浏览49
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要